MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research

Author:

Lucien Fabrice12ORCID,Gustafson Dakota345,Lenassi Metka6ORCID,Li Bo78,Teske Jacob J.1,Boilard Eric9,von Hohenberg Katharina Clemm10,Falcón‐Perez Juan Manual1112ORCID,Gualerzi Alice13ORCID,Reale Antonia14,Jones Jennifer C.15,Lässer Cecilia16,Lawson Charlotte17,Nazarenko Irina1819ORCID,O'Driscoll Lorraine20,Pink Ryan21ORCID,Siljander Pia R‐M22ORCID,Soekmadji Carolina23,Hendrix An24,Welsh Joshua A25ORCID,Witwer Kenneth W.25ORCID,Nieuwland Rienk8ORCID

Affiliation:

1. Department of Urology Mayo Clinic Rochester Minnesota USA

2. Department of Immunology Mayo Clinic Rochester Minnesota USA

3. Department of Laboratory Medicine & Pathobiology University of Toronto Toronto Ontario Canada

4. Toronto General Hospital Research Institute Toronto Ontario Canada

5. Department of Public Health Sciences Queen's University Kingston Ontario Canada

6. Institute of Biochemistry and Molecular Genetics, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

7. Department of Laboratory Medicine Nanfang Hospital, Southern Medical University Guangzhou China

8. Laboratory of Experimental Clinical Chemistry, and Amsterdam Vesicle Center Amsterdam UMC location AMC Amsterdam Netherlands

9. Centre de Recherche du CHU de Québec – Université Laval, Département de microbiologie et immunologie Faculté de Médecine de l'Université Laval Québec Quebec Canada

10. Translational Lymphoma Research Group German Cancer Research Center DKFZ Heidelberg Germany

11. Exosomes laboratory and Metabolomics Platform CIC bioGUNE‐BRTA Derio Spain

12. IKERBASQUE, Basque Foundation for Science Bilbao Spain

13. IRCCS Fondazione Don Carlo Gnocchi Milan Italy

14. Division of Blood Cancers Monash University ‐ Alfred Health Melbourne Victoria Australia

15. Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA

16. Krefting Research Centre, Institute of Medicine at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

17. Comparative Biomedical Sciences Royal Veterinary College London UK

18. Institute for Infection Prevention and Control, Faculty of Medicine University of Freiburg, Freiburg, Germany, German Cancer Consortium

19. Partner Site Freiburg and German Cancer Research Center Heidelberg Germany

20. School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute & Trinity St. James's Cancer Institute Trinity College Dublin Dublin Ireland

21. Faculty Health and Life Sciences Oxford Brookes University Oxford United Kingdom of Great Britain and Northern Ireland

22. EV‐group, Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, and Drug Research Program, Faculty of Pharmacy, Division of Pharmaceutical Biosciences University of Helsinki Helsinki Finland

23. School of Biomedical Sciences, Faculty of Medicine University of Queensland Brisbane Australia

24. Laboratory of Experimental Cancer Research, Department of Human Structure and Repair Ghent University Ghent Belgium

25. School of Medicine, Department of Molecular and Comparative Pathobiology, and Department of Neurology Johns Hopkins University Baltimore Maryland United States

Abstract

AbstractBlood is the most commonly used body fluid for extracellular vesicle (EV) research. The composition of a blood sample and its derivatives (i.e., plasma and serum) are not only donor‐dependent but also influenced by collection and preparation protocols. Since there are hundreds of pre‐analytical protocols and over forty variables, the development of standard operating procedures for EV research is very challenging. To improve the reproducibility of blood EV research, the International Society for Extracellular Vesicles (ISEV) Blood EV Task Force proposes standardized reporting of (i) the applied blood collection and preparation protocol and (ii) the quality of the prepared plasma and serum samples. Gathering detailed information will provide insight into the performance of the protocols and more effectively identify potential confounders in the prepared plasma and serum samples. To collect this information, the ISEV Blood EV Task Force created the Minimal Information for Blood EV research (MIBlood‐EV), a tool to record and report information about pre‐analytical protocols used for plasma and serum preparation as well as assays used to assess the quality of these preparations. This tool does not require modifications of established local pre‐analytical protocols and can be easily implemented to enhance existing databases thereby enabling evidence‐based optimization of pre‐analytical protocols through meta‐analysis. Taken together, insight into the quality of prepared plasma and serum samples will (i) improve the quality of biobanks for EV research, (ii) guide the exchange of plasma and serum samples between biobanks and laboratories, (iii) facilitate inter‐laboratory comparative EV studies, and (iv) improve the peer review process.

Publisher

Wiley

Subject

Cell Biology,Histology

Reference46 articles.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3